Puruisheng is a company that provides full-process medical device product registration and consulting services. It is committed to providing a full range of personalized clinical research solutions that meet international standards and make full use of human connections and regional resources. The services cover new drug development evaluation and Consulting, registry affairs, clinical trial implementation, data management, statistical analysis and medical affairs training, etc. Recently, Priusen completed a financing of hundreds of millions of RMB, led by Hangzhou Taikun Fund. Shanghai Boquan Baifei Equity Investment Partnership (Limited Partnership) and Hangzhou Jiuyue Venture Capital Partnership (Limited Partnership) also participated in this round of financing. . This round of financing is mainly used for team expansion, new service development and market promotion of mature services, creating a high-standard CRO industry benchmark.
This article is reproduced from: https://www.itjuzi.com/investevent/13318058
This site is for inclusion only, and the copyright belongs to the original author.